Applied Clinical Trials
Next week at DIA, two of TransCelerate?s Risk Based Monitoring workstream members will take their newly released methodology to the people.
Creating a Framework for Increased Accessibility in Palliative Care Research
With inequalities in palliative care provisions, recent study seeks to create a more equitable, diverse, and inclusive framework based on Patient and Public Involvement.
Bringing the Clinical Trials Industry Together
Micah Lieberman, Executive Director, Conferences (CHI) & Co-Founder, VP, Community and Business Development (ClinEco) discusses what ClinEco is and what attendees can expect at SCOPE.
Accelerating Time to Treatment in Rare Disease
Life sciences leaders are overcoming challenges to speed the development, launch, and education of novel medicines for rare diseases.
Managing Digital Studies in the Current Landscape
Flo Mowlem, VP of Science at ObvioHealth discusses digital study design—touching on how to best manage data and medical devices.
Generational Differences Among African Americans, Their Experiences with the Healthcare System
A study exploring healthcare preference and experience in this population group uncovers new insights and opportunities related to clinical research participation.
The Current State of Diversity in Randomized Clinical Trials for Peripheral Artery Disease
With significant race and sex disparities in the area of peripheral artery disease, a study shows that clinical trials often lack representative patient populations.
2 Commerce Drive Cranbury, NJ 08512